Register Now

Dear colleagues,

We are pleased to announce the WuXi Healthcare Forum 2021 will launch virtually March 15-18, 2021.

This complimentary event, titled "Partnership for Patients," will bring together 6,000+ colleagues from around the world who are working to address global healthcare challenges with global solutions. We will explore critical issues that impact our ability to advance medicines faster for patients and to shape the future of healthcare. The forum will delve into these timely topics through a variety of mediums to include plenary sessions, satellite forums by our partners, CEO roundtables, and regional tracks.

We are greatly honored by the support from our distinguished speakers below (partial list), and we invite you to join the conversation. Please click HERE to register.

Aki Tobaru, Partner, Remiges Ventures

Alex Mayweg, Managing Director, Versant Ventures

Andy Plump, President of R&D, Takeda

Anya Eldan, VP and Head of Startup Division, Israel Innovation Authority

Barry Heavey, Managing Director, Accenture

Bernd Goergen, Partner, High-Tech Gruenderfonds

Bernhardt Zeiher, CMO, Astellas Pharma

Caroline Xu, Co-Founder & CEO, ViGeneron

Casper Breum, Senior Advisor, Lundbeckfonden Ventures

Chandra Leo, Partner, HBM Partners

Chris Kim, Managing Director, Novatio Ventures

Chris Martin, CEO, Co-Founder and Director, ADC Therapeutics

Chris Molloy, CEO, Medicines Discovery Catapult

Cyriac Roeding, Co-Founder and CEO, Earli

Damian O'Connell, CEO, Experimental Therapeutics Development Centre, A*STAR

Dan Wang, Head of Johnson & Johnson Innovation, Asia Pacific

Danny Soon, CEO, Consortium for Clinical Research and Innovation Singapore

Darrin Morrissey, CEO, National Institute for Bioprocessing Research and Training, Ireland

David Aviezer, Chairman, MetaboMed and FRONT BioPharma; Associate Professor, Adjunct, Bar-Ilan University

Edward Hu, Vice Chairman and Chief Investment Officer, WuXi AppTec

Emmanuel Dowdall, Global EVP and CEO Asia Pacific, IDA Ireland

Ena Prosser, Partner, Fountain Healthcare Partners

Geert-Jan Mulder, Managing Partner, Forbion

Genya Dana, Head of Health Care Transformation, World Economic Forum

George Vradenburg, Convener, Global CEO Initiative on Alzheimer's Disease; Co-Chair, Davos Alzheimer's Collaborative; Chairman & Co-Founder, UsAgainstAlzheimer's

Haru Morita, Chairman & CEO, Modalis Therapeutics

Hui Cai, Forum Chair; VP and Head of Content Division, WuXi AppTec

Ian Tomlinson, Chairman, Apollo Therapeutics; Chairman, Start Codon

Ioannis Sapountzis, Corp. SVP and Global Head of BD&L, Boehringer Ingelheim

James Bradner, President, Novartis Institutes for Biomedical Research

James Jungkue Lee, CEO, Bridge Biotherapeutics

Jason Kelly, Co-Founder and CEO, Ginkgo Bioworks

Jim Naismith, Director, Rosalind Franklin Institute

Jin-San Yoo, President & CEO, PharmAbcine

Jordi Montserrat, Co-Founder and Managing Partner, Venturelab

Julian Adams, CEO, Gamida Cell

Julie Brady, Business Development Manager, Drug Discovery Unit, University of Dundee

Justin Kao, Venture Partner, Khosla Ventures

Kathryn Chapman, Deputy Director, Milner Therapeutics Institute, University of Cambridge

Khoo Shih, Managing Director, Life Sciences Investments, Temasek

Kyoung Kim, EVP, CHA Biotech

Lauren Lee, SVP, Head of Global R&D Innovation, Hanmi Pharmaceuticals

Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute

Leah Klapper, CTO, FutuRx

Leon Wang, EVP of International & China President, AstraZeneca

Makoto (Mark) Ohori, Partner, UTokyo Innovation Platform

Marcus Kostka, CEO, Abalos Therapeutics

Marianne De Backer, Head of Strategy, BD&L and Member of the Pharmaceuticals Executive Committee, Bayer

Mark Noguchi, SVP and Head of Business Development, Chugai Pharmaceutical

Martin Shanahan, CEO, IDA Ireland

Mary Kerr, CEO, NeRRe Therapeutics

Mayu Morishima, Executive Officer & Biotech Lead Capitalist, Beyond Next Ventures

Michael Altorfer, CEO, Swiss Biotech Association

Michael Curtis, President of R&D, eGenesis

Misti Ushio, CEO, TARA Biosystems

Nisa Leung, Managing Partner, Qiming Venture Partners

Opher Shapira, CEO, Yeda R&D, The Weizmann Institute of Science

Piers Ingram, CEO, Hummingbird Bioscience

Rafaèle Tordjman, Founder & CEO, Jeito Capital

Ram Aiyar, CEO, Korro Bio

Sakae Asanuma, President, Taiho Ventures

Steve Yang, Co-CEO, WuXi AppTec

Tai Harada, Manager & VP of US Operation, Fast Track Initiative

Ulf Grawunder, Chief Operating Officer and Chief Development Officer, NBE Therapeutics

Vijay Pande, General Partner, Andreessen Horowitz

XQ Lin, Group President & CEO, Esco Group; Chairman, EVX Ventures

Yanay Ofran, Founder & CEO, Biolojic Design

Yaron Daniely, Head of aMoon Alpha; Investment Lead, aMoon Velocity